Self-management of oral anticoagulation in children with congenital heart disease;Selvstyring af peroral antikoagulationsbehandling hos børn med medfødte hjertesygdomme

Ugeskrift for Laeger

Volumn 164, Issue 36, 2002, Pages 4173-4177

  Christensen, Thomas Decker ^a   Attermann, Jørn ^a   Hjortdal, Vibeke Elisabeth ^a   Maegaard, Marianne ^a   Hasenkam, John Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ANTICOAGULATION; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; MALE; MANAGEMENT; PATIENT SATISFACTION; PRACTICE GUIDELINE; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; MALE; PARENTS; PATIENT EDUCATION; SELF ADMINISTRATION;

EID: 0037008935     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Andrew M, Marzinotte V, Brooker LA, Adams M, Ginsberg J, Freedom R et al. Peroral anticoagulation therapy in pediatric patients: A prospective study. Thromb Haemost 1994; 71: 265-9.
2. Buck ML. Anticoagulation with warfarin in infants and children. Ann Pharmacother 1996; 30: 1316-22.
3. Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 1995; 108 (suppl 4): 506S-522S.
4. Spevak PJ, Freed MD, Castaneda AR, Norwood WI, Pollack P. Valve replacement in children less than 5 years of age. J Am Coll Cardiol 1986; 8: 901-8.
5. Vosa C, Renzulli A, Lombardi PF, Damiani G. Mechanical valve replacement under 12 years of age: 15 Years of experience. J Heart Valve Dis 1995; 4: 279-83.
6. Massicotte P, Marzinotte V, Vegh P, Adams M, Andrew M. Home monitoring of warfarin therapy in children with a whole blood prothrombin monitor. J Pediatr 1995; 127: 389-94.
7. Körfer R, Körtke H. ESCAT - Early self-controlled anticoagulation trial. I: Krian A, Matloff JM, Nicoloff DM, eds. Advancing the Technology of Bileaflet Mechanical Heart Valves. Darmstadt: Steinkopff Verlag, 1998: 12-22.
8. Hasenkam JM, Kimose HH, Knudsen L, Grønnesby H, Halborg J, Christensen TD et al. Self management of anticoagulant therapy after heart valve replacement. Eur J Cardio-Thoracic Surg 1997; 11: 935-42.
9. Horstkotte D, Piper C, Wiemar M. Optimal frequency of patient monitoring and intensity of peroral anticoagulation therapy in valvular heart-disease. J Thromb Thrombolys 1998; 5: S19-S24.
10. Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable international normalized ratio monitor in outpatients receiving long-term peroral anticoagulant therapy: Comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-7.
11. Cabalka AK, Emery RW, Petersen Rj, Helseth HK, Jakkula M, Arom KV et al. Long-term follow-up of the St. Jude Medical prosthesis in pediatric patients. Ann Thorac Surg 1995; 60: S618-S623.
12. Steffensen FH, Kristensen K, Ejlersen E, Dahlerup JF, Sørensen HT. Major haemorrhagic complications during peroral anticoagulant therapy in a Danish population-based cohort. J Int Med 1997; 242: 497-503.